Testing a sedative to prevent breathing problems during fertility procedures

This trial is testing whether a medication called remimazolam can prevent dangerous drops in oxygen levels during sedated hysteroscopy—a common procedure used to diagnose and treat fertility issues. The study will compare remimazolam to a standard sedative called propofol, both combined with pain relief medication. Researchers believe this medication may be safer for overweight and obese patients, who are at higher risk of breathing problems during sedation.

Low oxygen levels are a common problem during sedated fertility procedures, especially for people who are overweight or obese. Early studies suggest that this medication may reduce this risk compared to the standard treatment, so researchers want to test this in a larger group of patients.